A biotechnology startup in Bengaluru is developing an experimental “liquid cornea” hydrogel therapy designed to repair damaged corneal tissue and potentially reduce the need for donor corneal transplants.
The treatment uses a bioengineered hydrogel biomaterial that is applied to the damaged cornea. When exposed to light, it solidifies and forms a transparent scaffold that supports cell growth and tissue regeneration.
This innovation is significant because corneal blindness affects millions worldwide, and there is a major shortage of donor corneas, with only about one donor cornea available for every 70 patients who need a transplant.
If successful, such regenerative therapies could transform how corneal injuries and diseases are treated.
Read the full article:
https://www.medboundtimes.com/biotechnology/hydrogel-liquid-cornea-therapy-for-corneal-blindness
Share your thoughts and stay tuned for more updates on emerging medical innovations.
MBH/AB